Dr Edward Tobinick claims that the drug can improve cognition in people with dementia when it is injected into the spine and the person is hung upside down.

Professor Clive Ballard says,

'Etanercept has only been trialled on a very small number of people and there are large gaps in the research. We cannot draw any conclusions from initial results and there have also been serious concerns about the validity of the research.

One million people will develop dementia in the next ten years, yet dementia research is desperately underfunded. We urgently need to invest in research if we are to identify treatments and defeat this devastating condition.

Professor Clive Ballard
Director of Research
Alzheimer's Society